IPO

IPO Synopsis

Nephrocare Health Services Ltd
Registered Office: 5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64 , Hyderabad - 500081 , Telangana , India.
Phone : +91 40 4240 8039   Fax:
Email :  cs@nephroplus.com  
Website :  www.nephroplus.com
Initial public offering of 18,943,020 equity shares of face value of Rs2/- each ("equity shares") of Nephrocare Health Services Limited ("the company" or the "company" or the "issuer") for cash at a price of Rs460/- per equity share face value of Rs2/- (including a securities premium of Rs458/- per equity share) ("offer price") aggregating to Rs871.05 crores ("offer") comprising a fresh issue of 7,690,162 equity shares of face value of Rs2/- each aggregating to Rs353.41 crores ("fresh issue") and an offer for sale of 11,253,102 equity shares of face value of Rs2/- each ("offered shares") aggregating to Rs517.64 crores , comprising an offer for sale of 1,521,728 equity shares of face value of Rs2/- each aggregating to Rs70.00 crores by Investcorp Private Equity Fund II and 1,604,907 equity shares of face value of Rs2/- each aggregating to Rs73.83 crores by Healthcare Parent Limited and 147,765 equity shares of face value of Rs2/- each aggregating to Rs6.80 crores by Investcorp Growth Opportunity Fund and 2,888,911 equity shares of face value of Rs2/- each aggregating to Rs132.89 crores by Edoras Investment Holdings Pte. Ltd. ("promoter selling shareholders") and 121,985 equity shares of face value of Rs2/- each aggregating to Rs5.61 crores by Investcorp India Private Equity Opportunity Limited and 3,089,663 equity shares of face value of Rs2/- each aggregating to Rs142.12 crores by International Finance Coproration and 1,433,468 equity shares of face value of Rs2/- each aggregating to Rs65.94 crores by 360 One Special Opportunities Fund - Series 9 and 444,675 equity shares of face value of Rs2/- each aggregating to Rs20.46 crores by 360 One Special Opportunities Fund - Series 10 ("other selling shareholders" and together with the promoter selling shareholders, the "selling shareholders" and such offer for sale by the selling shareholders, the "offer for sale"). The offer constituted 18.88% of the post-offer paid-up equity share capital of the company.
Issue Money Payable On
Opens On Closes On Application Allotment
10-Dec-25 12-Dec-25 Rs 460.00-0.00 Rs 0.00-0.00
Minimum Application for shares in Nos :32  Further Multiples of :32
  (Rs Cr) Lead Managers to the Issue
Project Cost 325.15
Ambit Private Limited
Project Financed through Current Offer 871.05
Post Issue Equity Share Capital 20.07
Issue Price Rs 460.00
Projects
Capital expenditure by our Company for opening new dialysis clinics in India General corporate purposes
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
Promoted By Listing At Registrar to the Issue
  Vikram Vuppala
  Bessemer Venture Partners Trus
  Edoras Investment Holdings Pte
 BSE
 NSE
No Data Found.

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)